What changed

On 2026-08-13, our application to TradeDay’s affiliate programme was approved (applied 2026-07-30). Our affiliate partners are now FTMO, Fintokei, The5%ers, Funded7 and TradeDay.

Commission runs at 15%, rising to 20% above $5,001 and 22.5% above $10,001 in monthly sales — higher than any of our other partnerships.

Why we disclose first

Partnership creates pressure to write more favourably. We counter it by disclosing the relationship up front and by keeping the record of what we verified before it existed.

The TradeDay figures we publish were checked on 2026-08-05, before the partnership: $13,394,795 across 11,681 trader payouts, verified on-chain by Payout Junction — exceeding the firm’s own “$10M+” claim, the only such case among the 31 firms we track. That check predates the partnership and remains in the payout verification tracker.

What we will not soften

Everything we record about TradeDay’s downsides stays, unchanged:

  • Passing gets you a simulated account. Moving to Funded Live requires $10,000 in cumulative profit or a fifth payout request, plus $156 per month per exchange in professional data fees
  • On the move to Funded Live, profit above $10,000 is forfeited
  • The firm performs discretionary offboarding and states openly that it weighs whether a trader withdrew early or in size
  • Execution broker and clearing firm are undisclosed, there is no segregation of funds, and no regulator to appeal a denied payout to (the firm itself states it is not registered with the SEC, CFTC, NFA or FINRA)
  • Accounts opened on or after 2026-07-26 carry a 45% consistency objective and lower payout caps

What this means for readers

If you buy through our link, we earn a commission. You pay no more than you otherwise would. Our policy that compensation does not affect ratings is set out in About.

We currently partner with FTMO (rated High), Fintokei (Medium), The5%ers and Funded7 (both Low), and now TradeDay. We publish low ratings for partners when the evidence says so, and TradeDay gets the same treatment. This page is informational, not investment advice.